Evidence
Microb Biotechnol. 2024 Apr;17(4):e14462. doi: 10.1111/1751-7915.14462.
ABSTRACT
Alzheimer’s disease is a complex and progressive condition that affects essential neurological functions such as memory and reasoning. In the brain, neuronal loss, synaptic dysfunction, proteinopathy, neurofibrillary tangles, and neuroinflammation are the hallmarks of Alzheimer’s disease pathophysiology. In addition, recent evidence has highlighted that microbes, whether commensal or pathogenic, also have the ability to interact with their host and to regulate its immune system, therefore participating in the exchanges that lead to peripheral inflammation and neuropathology. Because of this intimate relationship, bacteria, viruses, fungi, and protozoa have been implicated in the development of Alzheimer’s disease. Here, we bring together current and most recent evidence of the role of microbes in Alzheimer’s disease, raising burning questions that need to be addressed to guide therapeutic approaches and potential prophylactic strategies.
PMID:38593310 | DOI:10.1111/1751-7915.14462
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Do microbes play a role in Alzheimer’s disease?
🌐 90 Days
VR Related Evidence Matrix
- Alterations of Gastrointestinal Microbe Composition in Various Human Diseases and Its Significance in the Early Diagnosis of Diseases
- Alterations of Gastrointestinal Microbe Composition in Various Human Diseases and Its Significance in the Early Diagnosis of Diseases
- Systemic inflammation in Ab1-40-induced Alzheimer's disease model: New translational opportunities
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Generating PET scan patterns in Alzheimer's by a mathematical model
- Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
- Disease-Modifying Treatments and Their Future in Alzheimer's Disease Management
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Genomic stress and impaired DNA repair in Alzheimer disease
- Adaptive immune changes associate with clinical progression of Alzheimer's disease
- Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis
- The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
- Advances in nanoprobes for molecular MRI of Alzheimer's disease
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Innate immune activation in neurodegenerative diseases
- Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke
- Is Alzheimer disease a disease?
- The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
- Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
- Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
- Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer's disease
- Association between hypothalamic Alzheimer's disease pathology and body mass index: The Hisayama study
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
- Targeting autophagy to counteract neuroinflammation: a novel antidepressant strategy
- Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
- The complement system in neurodegenerative diseases
- Bacteroides fragilis aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota
- Sonic Hedgehog Signalling Pathway Contributes in Age-Related Disorders and Alzheimer's Disease
- Multiple system atrophy with amyloid-b-predominant Alzheimer's disease neuropathologic change
- Hypoxia inducible factor-1a regulates microglial innate immune memory and the pathology of Parkinson's disease
- Interleukins in liver disease treatment
- Benefits of Music Therapy in the Cognitive Impairments of Alzheimer's-Type Dementia: A Systematic Review
- Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia
- The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review
- Pathogenic Potential of Eomesodermin-Expressing T-Helper Cells in Neurodegenerative Diseases
- Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems
- Effects of tooth loss on behavioral and psychological symptoms of dementia in app knock-in mice
- Alzheimer's Disease and Suicide: An Integrative Literature Review
- Cerebral malaria pathogenesis: Dissecting the role of CD4+ and CD8+ T-cells as major effectors in disease pathology
- Reduced STMN2 and pathogenic TDP-43, two hallmarks of ALS, synergize to accelerate motor decline in mice
- Brain hypothyroidism silences the immune response of microglia in Alzheimer's disease animal model
- Alzheimer's Disease Diagnosis in the Preclinical Stage: Normal Aging or Dementia
- Mechanisms of sex differences in Alzheimer's disease
- Loss of GDE2 leads to complex behavioral changes including memory impairment
- Genetic overlap between Alzheimer's disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Current and further outlook on the protective potential of Antrodia camphorata against neurological disorders
- NLRP3 inflammasome signalling in Alzheimer's disease
- Profiling of long non-coding RNAs in hippocampal-entorhinal system subfields: impact of RN7SL1 on neuroimmune response modulation in Alzheimer's disease
- Exploring morphological similarity and randomness in Alzheimer's disease using adjacent grey matter voxel-based structural analysis
- Cell type-specific functions of Alzheimer's disease endocytic risk genes
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- E2F1 Mediates Traumatic Brain Injury and Regulates BDNF-AS to Promote the Progression of Alzheimer's Disease
- E2F1 Mediates Traumatic Brain Injury and Regulates BDNF-AS to Promote the Progression of Alzheimer's Disease
- Cross-regulation between the immune system and the extracellular matrix during lung pathology
- Synaptic density patterns in early Alzheimer's disease assessed by independent component analysis
- Dynamics of N6-methyladenosine modification during Alzheimer's disease development
- Using Drosophila amyloid toxicity models to study Alzheimer's disease
Evidence Blueprint
Do microbes play a role in Alzheimer’s disease?
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Do microbes play a role in Alzheimer’s disease?
🌐 365 Days
VR Related Evidence Matrix
- Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
- Alterations of Gastrointestinal Microbe Composition in Various Human Diseases and Its Significance in the Early Diagnosis of Diseases
- Alterations of Gastrointestinal Microbe Composition in Various Human Diseases and Its Significance in the Early Diagnosis of Diseases
- Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer's disease via impacting on peripheral innate immune cells
- Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease
- Systemic inflammation in Ab1-40-induced Alzheimer's disease model: New translational opportunities
- Acetobacter pasteurianus BP2201 alleviates alcohol-induced hepatic and neuro-toxicity and modulate gut microbiota in mice
- Porphyromonas gingivalis, neuroinflammation and Alzheimer's disease
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Deregulation of the Glymphatic System in Alzheimer's Disease: Genetic and Non-Genetic Factors
- TDP-43 and Alzheimer's Disease Pathology in the Brain of a Harbor Porpoise Exposed to the Cyanobacterial Toxin BMAA
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Translocation of gut commensal bacteria to the brain
- The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap
- Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview
- Hepatic Oxi-Inflammation and Neophobia as Potential Liver-Brain Axis Targets for Alzheimer's Disease and Aging, with Strong Sensitivity to Sex, Isolation, and Obesity
- Amidst an amygdala renaissance in Alzheimer's disease
- Generating PET scan patterns in Alzheimer's by a mathematical model
- UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS
- Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model
- Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
- Disease-Modifying Treatments and Their Future in Alzheimer's Disease Management
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
- Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease
- Lipids and lipoproteins may play a role in the neuropathology of Alzheimer's disease
- Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease
- Genomic stress and impaired DNA repair in Alzheimer disease
- Adaptive immune changes associate with clinical progression of Alzheimer's disease
- Microglial regulation of brain function and pathological changes
- N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer's disease
- Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease
- A More Holistic Perspective of Alzheimer's Disease: Roles of Gut Microbiome, Adipocytes, HPA Axis, Melatonergic Pathway and Astrocyte Mitochondria in the Emergence of Autoimmunity
- Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
- The Role of Cerebellum in Alzheimer's Disease: A Forgotten Research Corner
- Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis
- Gut mycobiome and metabolic diseases: The known, the unknown, and the future
- The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
- Age, Sex and Alzheimer's disease: A longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients
- Advances in nanoprobes for molecular MRI of Alzheimer's disease
- Primary Hypothyroidism and Alzheimer's Disease: A Tale of Two
- Uncovering the Significance of STEP61 in Alzheimer's Disease: Structure, Substrates, and Interactome
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- Decoding metabolic signatures in Alzheimer's disease: a mitochondrial perspective
- GABA-Transaminase: A Key Player and Potential Therapeutic Target for Neurological Disorders
- Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease
- The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
- Microglial extracellular vesicles induce Alzheimer's disease-related cortico-hippocampal network dysfunction
- Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease
- Hotspots and trends of microglia in Alzheimer's disease: a bibliometric analysis during 2000-2022
- The elusive role of herpesviruses in Alzheimer's disease: current evidence and future directions
- Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease
- Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease
- Biomarkers associated with the pathogenesis of Alzheimer's disease
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Neuropathology of Alzheimer's Disease
- The Role of RIN3 Gene in Alzheimer's Disease Pathogenesis: a Comprehensive Review
- T lymphocytes in the pathogenesis and progression of Alzheimer's disease: pursuing direct neuropathological evidence
- Novel crosstalk mechanisms between GluA3 and Epac2 in synaptic plasticity and memory in Alzheimer's disease
- Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases
- Dysregulated glial genes in Alzheimer's disease are essential for homeostatic plasticity: Evidence from integrative epigenetic and single cell analyses
- Blood-brain barrier pathology in cerebral small vessel disease